208 related articles for article (PubMed ID: 6334522)
1. Transport of deoxycoformycin in human erythrocytes. Measurement by adenosine deaminase titration and radioisotope assays.
Chen SF; Stoeckler JD; Parks RE
Biochem Pharmacol; 1984 Dec; 33(24):4069-79. PubMed ID: 6334522
[TBL] [Abstract][Full Text] [Related]
2. Role of nucleoside transport in drug action. The adenosine deaminase inhibitor, deoxycoformycin, and the antiplatelet drugs, dipyridamole and dilazep.
Parks RE; Dawicki DD; Agarwal KC; Chen SF; Stoeckler JD
Ann N Y Acad Sci; 1985; 451():188-203. PubMed ID: 3878117
[No Abstract] [Full Text] [Related]
3. An enzymatic kinetic method for the determination of 2'-deoxycoformycin in biological fluids.
Staubus AE; Weinrib AB; Malspeis L
Biochem Pharmacol; 1984 May; 33(10):1633-7. PubMed ID: 6610419
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of 2'-deoxycoformycin, an inhibitor of adenosine deaminase, in the rat.
Geiger JD; Lewis JL; MacIntyre CJ; Nagy JI
Neuropharmacology; 1987 Sep; 26(9):1383-7. PubMed ID: 3499581
[TBL] [Abstract][Full Text] [Related]
5. Energy metabolism in adenosine deaminase-inhibited human erythrocytes.
Buc HA; Thuillier L; Hamet M; Garreau F; Moncion A; Pérignon JL
Clin Chim Acta; 1986 Apr; 156(1):61-9. PubMed ID: 3486057
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acute lymphoblastic leukemia with the adenosine deaminase inhibitor 2'-deoxycoformycin.
Mitchell BS; Koller CA; Kelley WN
Adv Exp Med Biol; 1979; 122B():347-50. PubMed ID: 317568
[No Abstract] [Full Text] [Related]
7. Tight binding inhibitors--VIII. Studies of the interactions of 2'-deoxycoformycin and transport inhibitors with the erythrocytic nucleoside transport system.
Rogler-Brown T; Parks RE
Biochem Pharmacol; 1980 Sep; 29(18):2491-7. PubMed ID: 6968561
[No Abstract] [Full Text] [Related]
8. Studies on inhibition of adenosine deaminase by isocoformycin in vitro and in vivo.
Shimazaki M; Kumada Y; Takeuchi T; Umezawa H; Watanabe K
J Antibiot (Tokyo); 1979 Jun; 32(6):654-8. PubMed ID: 468739
[TBL] [Abstract][Full Text] [Related]
9. Specificity of 2'-deoxycoformycin inhibition of adenosine metabolism in intact human skin fibroblasts.
Holland MJ
Res Commun Chem Pathol Pharmacol; 1986 Mar; 51(3):311-24. PubMed ID: 3486439
[TBL] [Abstract][Full Text] [Related]
10. Adenosine and cyclic AMP in rat cerebral cortical slices: effects of adenosine uptake inhibitors and adenosine deaminase inhibitors.
Nimit Y; Skolnick P; Daly JW
J Neurochem; 1981 Mar; 36(3):908-12. PubMed ID: 6259294
[TBL] [Abstract][Full Text] [Related]
11. Hemolysis in mice treated with deoxycoformycin, an inhibitor of adenosine deaminase.
Smith CM; Belch A; Henderson JF
Biochem Pharmacol; 1980 Apr; 29(8):1209-10. PubMed ID: 6966932
[No Abstract] [Full Text] [Related]
12. Deoxyadenosine triphosphate accumulation in erythrocytes of deoxycoformycin-treated mice.
Smith CM; Henderson JF
Biochem Pharmacol; 1982 Apr; 31(8):1545-51. PubMed ID: 6980005
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
Bontemps F; Van den Berghe G
Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493
[TBL] [Abstract][Full Text] [Related]
14. The clinical pharmacology of the adenosine deaminase inhibitor 2'-deoxycoformycin.
Smyth JF; Paine RM; Jackman AL; Harrap KR; Chassin MM; Adamson RH; Johns DG
Cancer Chemother Pharmacol; 1980; 5(2):93-101. PubMed ID: 6970630
[TBL] [Abstract][Full Text] [Related]
15. Transport and metabolism of adenosine in human erythrocytes: effect of transport inhibitors and regulation by phosphate.
Plagemann PG
J Cell Physiol; 1986 Sep; 128(3):491-500. PubMed ID: 3488996
[TBL] [Abstract][Full Text] [Related]
16. In vivo inhibition of adenosine deaminase by 2'-deoxycoformycin in mouse blood and leukemia L1210 cells.
Agarwal RP
Biochem Pharmacol; 1980 Feb; 29(2):187-93. PubMed ID: 6965857
[No Abstract] [Full Text] [Related]
17. Isolation of deoxycoformycin-resistant cells with increased levels of adenosine deaminase.
Hoffee PA; Hunt SW; Chiang J
Somatic Cell Genet; 1982 Jul; 8(4):465-77. PubMed ID: 6981855
[TBL] [Abstract][Full Text] [Related]
18. Nitrobenzylthioinosine-sensitive nucleoside transport system: mechanism of inhibition by dipyridamole.
Jarvis SM
Mol Pharmacol; 1986 Dec; 30(6):659-65. PubMed ID: 3785142
[TBL] [Abstract][Full Text] [Related]
19. Clinical, pharmacologic, and immunologic effects of 2'-deoxycoformycin.
Cummings FJ; Crabtree GW; Wiemann MC; Spremulli EN; Parks RE; Calabresi P
Clin Pharmacol Ther; 1988 Nov; 44(5):501-9. PubMed ID: 3263248
[TBL] [Abstract][Full Text] [Related]
20. Low-dose deoxycoformycin in lymphoid malignancy.
Grever MR; Leiby JM; Kraut EH; Wilson HE; Neidhart JA; Wall RL; Balcerzak SP
J Clin Oncol; 1985 Sep; 3(9):1196-201. PubMed ID: 2993534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
